Gerhardt Wagner
Psychiatry · Rochester, NYNPI 1477716199
Payments from drug & device makers
Across 279 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$929
- Lundbeck LLC$834
- Vanda Pharmaceuticals Inc.$671
- Otsuka America Pharmaceutical, Inc.$664
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$471
- Bausch Health US, LLC$432
- plus $1K from 13 others
What the payments were for
- Food & beverage$5,287100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $929 |
| Lundbeck LLC | 35 | $834 |
| Vanda Pharmaceuticals Inc. | 25 | $671 |
| Otsuka America Pharmaceutical, Inc. | 51 | $664 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $471 |
| Bausch Health US, LLC | 23 | $432 |
| Neurocrine Biosciences, Inc. | 11 | $263 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $218 |
| Sunovion Pharmaceuticals Inc. | 21 | $195 |
| Alkermes, Inc. | 7 | $148 |
| Johnson & Johnson | 6 | $134 |
| Axsome Therapeutics, Inc. | 6 | $109 |
| Teva Pharmaceuticals USA, Inc. | 4 | $73 |
| Supernus Pharmaceuticals, Inc. | 4 | $66 |
| Corium, LLC | 1 | $24 |
| Neuronetics, Inc. | 2 | $23 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
How this compares
$5,297 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine OdtClozapine | 24 | $13,460 |
| TrintellixVortioxetine Hydrobromide | 23 | $10,630 |
| Bupropion XlBupropion Hcl | 97 | $2,062 |
| Aripiprazole | 29 | $823 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $593 |
| Haloperidol | 12 | $542 |
| Duloxetine Hcl | 28 | $542 |
| Fluoxetine Hcl | 48 | $531 |
| Buspirone Hcl | 38 | $406 |
| Sertraline Hcl | 29 | $361 |
| Mirtazapine | 24 | $317 |
| Divalproex Sodium | 14 | $286 |
| Propranolol Hcl | 18 | $217 |
| Escitalopram Oxalate | 21 | $193 |
| Trazodone Hcl | 24 | $184 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $218 | $10,63023 claims |
| Almatica Pharma LLCSertraline Hcl | $12 | $36129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in Rochester
- Anton PorsteinssonRochester$7.6M
- M IsmailRochester$742K
- Tulio OrtegaRochester$492K
- Elyssa BarronWhite Plains$12.8M
- Mark DibuonoStaten Island$11.9M
- Ronald BrennerHempstead$11.5M
- Michael LiebowitzNew York$7.1M
- Leslie CitromePomona$5.7M
- John KaneGlen Oaks$4M
- Inna Yuryev-GolgerBrooklyn$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.